Reinstituting warfarin in patients who develop warfarin skin necrosis

Anand Jillella, Charles L. Lutcher

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Skin necrosis is a rare but serious complication of oral anticoagulation with coumarin derivatives. Frequently, the necrosis can be extensive and may result in major morbidity and mortality. The majority of these patients require prolonged anticoagulation for life-threatening conditions such as deep venous thrombosis and pulmonary embolism. Resuming oral anticoagulants in the face of skin necrosis is a difficult decision for both the patient and the physician. Because long-term heparin therapy is inconvenient and is associated with significant side effects, we reviewed the literature to find alternative treatment strategies. A Medline search was done, and all papers published in English since 1987 were reviewed. Of 58 cases with skin necrosis attributed to oral anticoagulants, oral anticoagulation was resumed in 7 patients with no resulting adverse effects. Warfarin is the most widely used coumarin derivative in the United States. Based on our review, we make recommendations for resuming warfarin in patients who have developed skin necrosis when the clinical condition absolutely requires prolonged anticoagulation.

Original languageEnglish (US)
Pages (from-to)117-119
Number of pages3
JournalAmerican Journal of Hematology
Volume52
Issue number2
DOIs
StatePublished - Jun 1 1996

Fingerprint

Warfarin
Necrosis
Skin
Coumarins
Anticoagulants
Pulmonary Embolism
Venous Thrombosis
Heparin
Morbidity
Physicians
Mortality
Therapeutics

Keywords

  • alternative strategies
  • anticoagulation
  • warfarin skin necrosis

ASJC Scopus subject areas

  • Hematology

Cite this

Reinstituting warfarin in patients who develop warfarin skin necrosis. / Jillella, Anand; Lutcher, Charles L.

In: American Journal of Hematology, Vol. 52, No. 2, 01.06.1996, p. 117-119.

Research output: Contribution to journalArticle

@article{68c805d260a5444eba973a3389ffea73,
title = "Reinstituting warfarin in patients who develop warfarin skin necrosis",
abstract = "Skin necrosis is a rare but serious complication of oral anticoagulation with coumarin derivatives. Frequently, the necrosis can be extensive and may result in major morbidity and mortality. The majority of these patients require prolonged anticoagulation for life-threatening conditions such as deep venous thrombosis and pulmonary embolism. Resuming oral anticoagulants in the face of skin necrosis is a difficult decision for both the patient and the physician. Because long-term heparin therapy is inconvenient and is associated with significant side effects, we reviewed the literature to find alternative treatment strategies. A Medline search was done, and all papers published in English since 1987 were reviewed. Of 58 cases with skin necrosis attributed to oral anticoagulants, oral anticoagulation was resumed in 7 patients with no resulting adverse effects. Warfarin is the most widely used coumarin derivative in the United States. Based on our review, we make recommendations for resuming warfarin in patients who have developed skin necrosis when the clinical condition absolutely requires prolonged anticoagulation.",
keywords = "alternative strategies, anticoagulation, warfarin skin necrosis",
author = "Anand Jillella and Lutcher, {Charles L.}",
year = "1996",
month = "6",
day = "1",
doi = "10.1002/(SICI)1096-8652(199606)52:2<117::AID-AJH9>3.0.CO;2-X",
language = "English (US)",
volume = "52",
pages = "117--119",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Reinstituting warfarin in patients who develop warfarin skin necrosis

AU - Jillella, Anand

AU - Lutcher, Charles L.

PY - 1996/6/1

Y1 - 1996/6/1

N2 - Skin necrosis is a rare but serious complication of oral anticoagulation with coumarin derivatives. Frequently, the necrosis can be extensive and may result in major morbidity and mortality. The majority of these patients require prolonged anticoagulation for life-threatening conditions such as deep venous thrombosis and pulmonary embolism. Resuming oral anticoagulants in the face of skin necrosis is a difficult decision for both the patient and the physician. Because long-term heparin therapy is inconvenient and is associated with significant side effects, we reviewed the literature to find alternative treatment strategies. A Medline search was done, and all papers published in English since 1987 were reviewed. Of 58 cases with skin necrosis attributed to oral anticoagulants, oral anticoagulation was resumed in 7 patients with no resulting adverse effects. Warfarin is the most widely used coumarin derivative in the United States. Based on our review, we make recommendations for resuming warfarin in patients who have developed skin necrosis when the clinical condition absolutely requires prolonged anticoagulation.

AB - Skin necrosis is a rare but serious complication of oral anticoagulation with coumarin derivatives. Frequently, the necrosis can be extensive and may result in major morbidity and mortality. The majority of these patients require prolonged anticoagulation for life-threatening conditions such as deep venous thrombosis and pulmonary embolism. Resuming oral anticoagulants in the face of skin necrosis is a difficult decision for both the patient and the physician. Because long-term heparin therapy is inconvenient and is associated with significant side effects, we reviewed the literature to find alternative treatment strategies. A Medline search was done, and all papers published in English since 1987 were reviewed. Of 58 cases with skin necrosis attributed to oral anticoagulants, oral anticoagulation was resumed in 7 patients with no resulting adverse effects. Warfarin is the most widely used coumarin derivative in the United States. Based on our review, we make recommendations for resuming warfarin in patients who have developed skin necrosis when the clinical condition absolutely requires prolonged anticoagulation.

KW - alternative strategies

KW - anticoagulation

KW - warfarin skin necrosis

UR - http://www.scopus.com/inward/record.url?scp=0029967231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029967231&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-8652(199606)52:2<117::AID-AJH9>3.0.CO;2-X

DO - 10.1002/(SICI)1096-8652(199606)52:2<117::AID-AJH9>3.0.CO;2-X

M3 - Article

VL - 52

SP - 117

EP - 119

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 2

ER -